Xconomy: Robotics and A.I.

Boston
Akili Interactive’s Video Game for ADHD Gets the FDA All Clear

National
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More
National
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
National
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More

1.
Data Quantity, Complexity Drives Use of AI in Drug Discovery and Testing | San Francisco
2.
Akili Interactive’s Video Game for ADHD Gets the FDA All Clear | Boston
3.
Biotech “Mapmaker” Immunai Launches With $20M to Chart the Immune System | New York
4.
Pliant Pushes Forward With IPO Plans to Back Fibrosis Drug Studies | San Francisco
5.
Lantern Pharma IPO File Illuminates Plan to “Rescue” Failed Cancer Drugs | Texas
6.
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More | National

Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
Frank Vinluan | National
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More
Sarah de Crescenzo | National
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More
Frank Vinluan | National
AI Can Unlock Health Data’s Potential, But Access Is Still Difficult
Jeff Bauter Engel | Wisconsin
AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund
Gareth Macdonald | National
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
Frank Vinluan | National
Nuance & Microsoft Team Up on Conversational AI for Doctors’ Offices
Jeff Bauter Engel | Boston
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
Bernadette Tansey | San Francisco
High-Flying Ginkgo Nets Another $290M to Program Cells Like Computers
Frank Vinluan | Boston

Read More Posts ›

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
How Big Is the US Market for Medical Devices & Technologies?
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

Sponsored · Whitepaper
The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson

Xconomy on Demand

We offer a number of ways to subscribe for free!